Cart summary

You have no items in your shopping cart.

SC144

SKU: orb1223006

Description

SC144 is an orally active small-molecule gp130 inhibitor.

Images & Validation

Key Properties

CAS Number895158-95-9
MW322.3
Purity>98% (HPLC)
FormulaC16H11FN6O
SMILESFc1cc2c(cc1)n1cccc1c(NNC(=O)c1cnccn1)n2
TargetDNA/RNA Synthesis
SolubilityDMSO : 19.5 mg/mL. 60.50 mM;

Bioactivity

In Vivo
SC144 (10 mg/kg; i.p.; daily for 58 days) suppresses tumor growth in human ovariancancer xenografts. SC144 (100 mg/kg; p.o. ; daily for 35 days) treatment shows the average tumor volume in mice 82% smaller than that in the control group. Animal model: Athymic mice (human ovarian cancer xenograft). Dosage: 10 mg/kg. Administration: I. p; daily for 58 days. Result: Significantly inhibited tumor growth by about 73%.
In Vitro
SC144 inhibits cell growth in a panel of human ovarian cancer cell lines with IC50s in a submicromolar range (IC50 = OVCAR-8, OVCAR-5, OVCAR-3= 0.72, 0.49, 0.95 μM). The potency of SC144 toward NCI/ADR-RES (Paclitaxel- and Doxorubicin-resistant, IC50 = 0.43 μM) and HEY (Cisplatin-resistant, IC50 = 0.88 μM) suggests an ability to overcome drug resistance in ovarian cancer. SC144 (2 μM; 24 hours) causes significantly more apoptosis in OVCAR-8 and Caov-3 than normal kidney epithelial and normal endometrial cells. SC144 (0.5-2 μM; 0-6 hours) substantially increases the phosphorylation of gp130 (S782) in both OVCAR-8 and Caov-3 cells in a time- and dose-dependent manner. SC144 is cytotoxic to ovarian cancer cells via a mechanism involving the inhibition of gp130 activity, leading to the inactivation of Akt and Stat3 as well as the suppression of Stat3-regulated gene expression. As are result, SC144 treatment eventually causes cell-cycle arrest, anti-angiogenesis, and apoptosis. Apoptosis Analysis Cell line: OVCAR-8 and Caov-3 cells. Concentration: 2 μM. Incubation time: 24 hours. Result: Significantly caused cell death in OVCAR-8 and Caov-3 cells. Western blot analysis. Cell line: OVCAR-8, Caov-3 cells. Concentration: 0.5-2 μM Incubation time: 0-6 hours. Result: Substantially increased the phosphorylation of gp130 (S782) in both OVCAR-8 and Caov-3 cellsin a time- and dose-dependent manner.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • SC144 [orb1300980]

    99.85% (May vary between batches)

    895158-95-9

    322.3

    C16H11FN6O

    50 mg, 100 mg, 5 mg, 10 mg, 25 mg, 1 ml x 10 mM (in DMSO)
  • SC144 hydrochloride [orb1909045]

    917497-70-2

    358.76

    C16H12ClFN6O

    2 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

SC144 (orb1223006)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

200 mg
500 mg
5 mg
$ 80.00
10 mg
$ 120.00
25 mg
$ 210.00
50 mg
$ 330.00
100 mg
$ 530.00